Structure, ingredient, and function-based biomimetic scaffolds for accelerated healing of tendon-bone interface.

At the same time, on the 7th day, proteoglycan levels in the BCT@GFs group were significantly higher than that in the control group (225.33 ± 5.43 μg/mL) and maintained an increasing trend until the 14th day ( Fig. 6 I).

also in 63,971 other papers

The degradation of composite BCT scaffolds showed a decreasing trend and reached 56.77 ± 5.31 % in the 21st week ( Fig. 3 D).

also in 47,180 other papers